A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Status:
Completed

Trial end date:
2018-04-27

Target enrollment:

Participant gender:

The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris

Phase 3

Dermira, Inc.